Representative before the EPO
CEO (Chief Executive Officer)

Partner/Owner

Employment test 11 - 50 employees
Company dna muller fottner steinecke
no operation time available
Headquarter in Munich and 1 office
active in Legal Services and IP Consulting

We have observed 119 EP applications Peter Steinecke has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after May 13, 2014). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP12825652

COMPOSITION HAVING IMPROVED HEAD STABILITY AND USE THEREOF

IPC classification:
C12C 5/02
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP12829075

OSTEOGENESIS PROMOTER AND USE THEREOF

IPC classification:
A61K 45/00, A61K 38/00, A61K 31/4439, A61K 31/44, A61K 31/428, A61K 31/427, A61K 31/426, A61K 31/42, A61K 31/4184, A61K 31/4035, A61K 31/381, A61K 31/352, A61K 31/196, A61K 31/194, A61K 31/121, A61P 43/00, A61P 19/08
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP12833989

SHIGELLA-DERIVED VECTOR AND METHODS OF USING THE SAME

IPC classification:
C12N 15/00
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12837135

EXOGENOUS OPIOID PEPTIDE-DEGRADING ENZYME

IPC classification:
A61K 38/46, A61K 35/74, A23L 1/305, C12N 9/58, C12N 9/48, A61P 39/02, A61P 25/18
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12840561

DELIVERY DEVICE

IPC classification:
A61M 37/00, A61M 35/00, A61B 17/20
Applicant:
The University of Queensland
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP12780184

COMPOUNDS FOR THE TREATMENT OF INFLUENZA

IPC classification:
A61K 31/155, C07C 279/16, C07C 275/14, A61P 31/16
Applicant:
Christian-Albrechts-Universität zu Kiel
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12847601

VASCULAR PROGENITOR CELL SHEET DERIVED FROM INDUCED PLURIPOTENT STEM CELLS, AND PRODUCTION METHOD THEREFOR

IPC classification:
A61L 27/00, A61K 35/12, C12N 5/10, C12M 3/04, C12M 1/00, A61P 17/02, A61P 9/10, A61P 9/00
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP12774992

WNT4 AND MED12 FOR USE IN THE DIAGNOSIS AND TREATMENT OF TUMOR DISEASES

IPC classification:
A61K 39/00, C12Q 1/68, C12N 15/11
Applicant:
Universität Bremen
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12853388

PRECIOUS METALS RECOVERY

IPC classification:
C22B 11/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12853028

BIOMARKER FOR LYMPHOCYTIC INFUNDIBULONEUROHYPOPHYSITIS, AND USE APPLICATIONS THEREOF

IPC classification:
G01N 33/564, G01N 33/53, C12N 15/09, C07K 16/18
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP12859252

ANTI-CANCER COMPOUNDS TARGETING RAL GTPASES AND METHODS OF USING THE SAME

IPC classification:
A61K 31/4162
Applicant:
The Regents of the University of Colorado
Applicant:
University of Virginia Patent Foundation
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP13700013

METHOD OF PROVIDING MONOCLONAL AUTO-ANTIBODIES WITH DESIRED SPECIFICITY

IPC classification:
A61K 39/395, C12N 15/13, C12N 5/0781, C07K 16/18, C07K 16/06, A61P 37/00
Applicant:
ImmunoQure AG
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP13700002

METHOD OF ISOLATING HUMAN ANTIBODIES

IPC classification:
A61K 39/395, C12N 15/13, C12N 5/0781, C07K 16/18, C07K 16/06, A61P 37/00
Applicant:
ImmunoQure AG
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP13736097

CELLULOSE DERIVATIVES FOR INHIBITING CRYSTALLIZATION OF POORLY WATER-SOLUBLE DRUGS

IPC classification:
A61K 47/38, A61K 47/30, A61K 31/70, A61K 9/08
Applicant:
Purdue Research Foundation (PRF)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP12811391

METHOD FOR DETECTING CHEMICAL AND PHYSICAL PHENOMENON, AND DEVICE THEREFOR

IPC classification:
H01L 27/14, G01N 27/414, G01N 27/00
Applicant:
Toyohashi University of Technology
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13702565

SCHIZOPHRENIA-RELATED ISOFORM OF KNCH2 AND DEVELOPMENT OF ANTIPSYCOTIC DRUGS

IPC classification:
C12Q 1/68
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13738396

NEW MICROORGANISM BELONGING TO YARROWIA GENUS, AND OIL DECOMPOSITION AGENT AND OIL DECOMPOSITION/REMOVAL METHOD USING SAME

IPC classification:
C12N 1/16, C02F 3/34
Applicant:
Nissan Chemical Industries, Ltd.
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP14184666

IRS modulators

IPC classification:
A61K 48/00, A61K 38/26, A61K 38/22, A61K 38/00, C12Q 1/68, A61P 5/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13764687

A NUCLEIC ACID DETECTION METHOD COMPRISING TARGET SPECIFIC INDEXING PROBES (TSIP) COMPRISING A RELEASABLE SEGMENT TO BE DETECTED VIA FLUORESCENCE WHEN BOUND TO A CAPTURE PROBE

IPC classification:
C40B 30/04, C12Q 1/68, C12P 19/34, C07H 21/00
Applicant:
Université Laval
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13712655

A NOVEL INTERFERON- 4 (IFNL4) PROTEIN, RELATED NUCLEIC ACID MOLECULES, AND USES THEREOF

IPC classification:
C12Q 1/70, C12Q 1/68, C07K 14/555
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13772033

MINIMALLY INVASIVE EPICARDIAL PACEMAKER

IPC classification:
A61N 1/362
Applicant:
University of Southern California
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13717459

NEW PYRIDO [3.4-C][1,9]PHENANTHROLINE AND 11, 12 DIHYDROPYRIDO [3.4 -C][1,9]PHENANTHROLINE DERIVATIVES AND THE USE THEREOF, PARTICULARLY FOR TREATING CANCER

IPC classification:
A61K 31/4745, C07D 471/14, A61P 35/00, A61P 33/00, A61P 31/12, A61P 31/10, A61P 31/04, A61P 31/00, A61P 29/00
Applicant:
Christian-Albrechts-Universität zu Kiel
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP13800857

METHODS AND COMPOSITIONS FOR THE INHIBITION OF PIN1

IPC classification:
A61K 31/473, C12N 9/90
Applicant:
The United States of America as Represented by the Secretary, Department of Health and Human Services
Applicant:
Beth Israel Deaconess Medical Center Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP13807160

METHOD AND COMPOSITION FOR DELIVERING A COMPOUND THROUGH A BIOLOGICAL BARRIER

IPC classification:
A61M 37/00, A61K 9/14
Applicant:
The University of Queensland
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13803471

OXIDOREDUCTASE REACTION CONTROL AND USE THEREOF

IPC classification:
C12P 7/40, C12P 7/24, C12P 7/04, C12N 9/04, C12N 9/02
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13826030

ANTAGONISTS OF THE TOLL-LIKE RECEPTOR 1/2 COMPLEX

IPC classification:
A61K 31/122, A61K 31/05
Applicant:
The Regents of the University of Colorado
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13879526

BROWN ADIPOCYTE DIFFERENTIATION-INDUCING AGENT

IPC classification:
A61K 48/00, A61K 38/00, A23L 1/305, A23L 1/30, C12Q 1/68, C12Q 1/02, C12N 15/09, C12N 5/0775, C12N 5/077, A61P 9/10, A61P 3/10, A61P 3/06, A61P 3/04
Applicant:
Chubu University Educational Foundation
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP13837496

PROTEASE-BASED BIOSENSOR

IPC classification:
G01N 33/542, C12Q 1/37, C12N 15/57, C12N 11/18, C12N 9/48, C07K 19/00
Applicant:
The University of Queensland
Agent:
James Ronald Nicholls, J A Kemp
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
PATENT GRANTED
EP13765328

HUMAN ISLET AMYLOID POLYPEPTIDE (HIAPP) SPECIFIC ANTIBODIES AND USES THEREOF

IPC classification:
A61K 39/395, G01N 33/68, G01N 33/577, C07K 16/18
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP13846893

INTEGRATION DYSFUNCTION SYNDROME MARKER SET AND UTILIZATION THEREOF

IPC classification:
G01N 33/53
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP13846189

OCULAR FILTRATION DEVICES, SYSTEMS AND METHODS

IPC classification:
A61M 31/00, A61F 9/007, A61F 2/14
Applicant:
The Regents of the University of Colorado
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13849133

METHODS FOR CLASSIFYING TUMORS AND USES THEREFOR

IPC classification:
G01N 33/574, C07K 16/18
Applicant:
The University of Queensland
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13848409

USE OF ENDOCYTOSIS INHIBITORS AND ANTIBODIES FOR CANCER THERAPY

IPC classification:
A61K 39/395, A61K 38/46, A61K 31/715, A61K 31/5415, A61K 31/4706, A61P 35/00
Applicant:
The University of Queensland
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14158403

Non-invasive assay for early detection of cancer

IPC classification:
C12Q 1/68
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
APPLICATION REFUSED
EP13863100

CELL-FREE BIOFRAGMENT COMPOSITIONS AND RELATED SYSTEMS, DEVICES, AND METHODS

IPC classification:
G01N 33/563, G01N 33/53, G01N 33/48
Applicant:
The University of Queensland
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP13860755

A METHOD OF REDUCING BRAIN AMYLOID PLAQUES USING ANTI-Ass ANTIBODIES

IPC classification:
A61K 49/00, A61K 39/395, C07K 16/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14700033

RECOMBINANT HUMAN ANTIBODIES FOR THERAPY AND PREVENTION OF POLYOMAVIRUS-RELATED DISEASES

IPC classification:
G01N 33/569, C07K 16/08
Applicant:
University of Zurich (Universität Zürich)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP14166923

Circulating miRNAs as early detection marker and prognostic marker

IPC classification:
C12Q 1/68
Applicant:
Heidelberg University (Ruprecht-Karls-Universität Heidelberg)
Applicant:
Deutsches Krebsforschungszentrum (DKFZ)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15166032

HUMAN ANTI-ALPHA-SYNUCLEIN ANTIBODIES

IPC classification:
C07K 16/18
Applicant:
University of Zurich (Universität Zürich)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14174835

Compositions comprising Phenylalanine and Leucine for use in the diagnosis and treatment of neurological disorders and symptoms thereof

IPC classification:
G01N 33/68, A61K 31/198
Applicant:
Aachen University (RWTH Aachen)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14763473

A METHOD OF ISOLATING CELLS FOR THERAPY AND PROPHYLAXIS

IPC classification:
A61K 45/00, C12N 5/073, C12N 5/074, C12N 5/0775, C12N 5/0789
Applicant:
The University of Queensland
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14764271

COMPOUNDS AND COMPOSITIONS FOR DRUG RELEASE

IPC classification:
A61P 31/04, A61L 31/10, A61L 29/16, A61L 29/08, A61L 15/44, A61L 15/22, A61K 47/48, A61K 31/496, A61L 31/16
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14763816

HYBRID NECROPTOSIS INHIBITORS

IPC classification:
A61K 31/4166
Applicant:
University of Houston
Applicant:
Harvard College
Applicant:
Tufts University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14773956

METHOD FOR IMMOBILIZING AND RELEASING MICROORGANISM

IPC classification:
C12N 15/09, C12N 1/21, C12N 11/00
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP14735323

STABILIZED HUMAN IMMUNODEFICIENCY VIRUS (HIV) ENVELOPE (ENV) TRIMER VACCINES AND METHODS OF USING THE SAME

IPC classification:
A61K 38/00
Applicant:
Beth Israel Deaconess Medical Center Inc
Agent:
Thomas Charles Leonard, Kilburn & Strode LLP
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14763917

THERAPEUTIC AGENT FOR SYSTEMIC BONE DISEASE AND USE THEREOF

IPC classification:
A61P 43/00, A61P 19/00, A61K 31/495
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14182939

Anti-LOXL4 antibodies and derivatives there

IPC classification:
A61K 39/00, A61P 35/00, A61K 39/395, C07K 16/40, C12N 9/06
Applicant:
Christian-Albrechts-Universität zu Kiel
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15180578

NOVEL ANTI-CD73 ANTIBODY

IPC classification:
G01N 33/574, C12Q 1/02, C12N 15/09, C07K 16/28
Applicant:
Fujita Health University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION IN PROGRESS
EP14818342

GLUCAN-ENCAPSULATED SIRNA FOR TREATING TYPE 2 DIABETES MELLITUS

IPC classification:
A61K 31/711, A61P 3/10, A61K 9/48, C12N 15/11
Applicant:
University of Massachusetts
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14735565

HUMAN ANTI-IL-32 ANTIBODIES

IPC classification:
C07K 16/24
Applicant:
ImmunoQure AG
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14822788

GENETIC AND IMAGE BIOMARKERS ASSOCIATED WITH DECLINE IN COGNITIVE MEASURES AND BRAIN GLUCOSE METABOLISM IN POPULATIONS WITH ALZHEIMER'S DISEASE OR THOSE SUSCEPTIBLE TO DEVELOPING ALZHEIMER'S DISEASE

IPC classification:
C12Q 1/68
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14838699

METHOD OF DETERMINING RESISTANCE TO INFLUENZA VIRUS

IPC classification:
G01N 33/569, G01N 33/53
Applicant:
Fujita Health University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14851250

STABILIZED HUMAN IMMUNODEFICIENCY VIRUS (HIV) CLADE C ENVELOPE (ENV) TRIMER VACCINES AND METHODS OF USING SAME

IPC classification:
C07K 14/16
Applicant:
Beth Israel Deaconess Medical Center Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
GRANT OF PATENT INTENDED
EP14850029

MODIFIED ss-GALACTOSIDASE

IPC classification:
C12P 19/14, C12N 9/38, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C12N 15/09
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14859759

DEVICES AND METHODS FOR CONTINUOUS DRUG DELIVERY VIA THE MOUTH

IPC classification:
A61K 9/22, A61C 7/08, A61M 37/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP16165848

DRUG DISCOVERY BASED ON IN VITRO DIFFERENTIATED CELLS

IPC classification:
C12N 5/07, C12Q 1/02
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14861896

PROTEIN PHOSPHATASE INHIBITORS THAT CROSS THE BLOOD BRAIN BARRIER

IPC classification:
C07D 493/08, A61P 35/00, A61K 31/496
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14869024

MODIFIED LIPASE AND USE THEREOF

IPC classification:
C12N 9/20, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, A23C 9/152, C12N 15/09
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14833579

ANTIBODY-BASED THERAPY OF TRANSTHYRETIN (TTR) AMYLOIDOSIS AND HUMAN-DERIVED ANTIBODIES THEREFOR

IPC classification:
C07K 16/18
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15709214

NOVEL COMPOUNDS CAPABLE OF ANTAGONIZING ISLET AMYLOID POLYPEPTIDE (IAPP) INDUCED BETA-CELL DAMAGE AND IMPAIRED GLUCOSE TOLERANCE

IPC classification:
C07K 16/18, A61P 3/10, A61K 39/00, A01K 67/027
Applicant:
University of Zurich (Universität Zürich)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14887019

ARTIFICIAL SKELETAL MATERIAL AND CONSTRUCTS FORMED THEREFROM

IPC classification:
A61K 38/18, A61F 2/28, A61B 17/58
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Agent:
Glyn John Truscott, Elkington and Fife LLP
Status:
EXAMINATION REQUESTED
EP16182598

SAFETY HINGE

IPC classification:
E05D 11/00, E05D 7/10
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
APPLICATION PUBLISHED
EP15727824

STABILIZED INFLUENZA HEMAGGLUTININ STEM REGION TRIMERS AND USES THEREOF

IPC classification:
A61K 39/145
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP14892965

HIGHLY EMULSIFIABLE ALBUMEN HYDROLYSATE

IPC classification:
A23L 15/00, A23J 1/08
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15819681

ANTI-CANCER COMPOUNDS TARGET RAL GTPASES AND METHODS OF USING THE SAME

IPC classification:
A61K 31/505
Applicant:
The Regents of the University of Colorado
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15831858

CARBONATED DRINK COMPRISING OMEGA, VITAMINS AND MINERALS

IPC classification:
A23L 2/52
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15834600

MODIFIED BETA-GALACTOSIDASE

IPC classification:
C12P 19/04, C12N 15/09, C12N 1/21, C12N 1/19, C12N 1/15, C12N 9/38
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP16166911

DRUG DISCOVERY BASED ON IN VITRO GENERATED TISSUE

IPC classification:
C12Q 1/02, C12N 5/07
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP15834013

AFFINITY PROTEINS AND USES THEREOF

IPC classification:
C07K 16/12, C12P 21/08, A61K 39/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15763242

THERAPEUTIC AND DIAGNOSTIC ANTI-LOXL4 ANTIBODIES

IPC classification:
A61K 39/00, A61P 35/00, A61K 39/395, C07K 16/40, C12N 9/06
Applicant:
Christian-Albrechts-Universität zu Kiel
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15760025

METHODS AND COMPOSITIONS FOR TREATING LEBER CONGENITAL AMAUROSIS

IPC classification:
C07K 14/435, A61K 48/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
EXAMINATION REQUESTED
EP15840637

HUMAN DOSING OF PHOSPHATASE INHIBITOR

IPC classification:
A61K 31/496
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17159896

TARGETED IDENTIFICATION OF IMMUNOGENIC PEPTIDES

IPC classification:
C07K 7/06, A61K 39/00
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The application has been published
EP15808356

PHARMACEUTICAL ANTI-TNF-ALPHA ANTIBODY FORMULATION

IPC classification:
A61K 39/00, A61K 47/00, A61K 47/18, A61K 47/10, A61K 39/395, C07K 16/24
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The patent has been granted
EP15867329

ANISOTROPIC CONSTRUCTS AND METHODS FOR FORMING AND USING SAME FOR TREATING DAMAGED BIOLOGICAL TISSUE

IPC classification:
A61F 2/02
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP14907906

REINFORCED VASCULAR PROSTHESES

IPC classification:
A61F 2/06
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP15866643

REINFORCED VASCULAR PROSTHESES

IPC classification:
A61K 35/42, A61F 2/04, A61F 2/86, A61F 2/07
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP15868784

ESTER-LINKED SURFACE MODIFYING MACROMOLECULES

IPC classification:
C09D 7/12, C09D 5/16
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17169749

ANTI-BETA-AMYLOID ANTIBODY AND USES THEREOF

IPC classification:
A61P 25/28, A61K 39/395, C07K 16/18
Applicant:
University of Zurich (Universität Zürich)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The application has been published
EP17174176

METHOD OF PROVIDING DISEASE-SPECIFIC BINDING MOLECULES AND TARGETS

IPC classification:
A61P 25/28, A61K 39/395, C07K 16/18
Applicant:
University of Zurich (Universität Zürich)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17174362

VACCINE FOR THE PREVENTION OF BREAST CANCER RECURRENCE

IPC classification:
C07K 16/32, A61K 39/00
Applicant:
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16700220

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) ANTIBODIES AND USES DERIVED THEREOF

IPC classification:
C07K 16/40, A61P 35/00, A61K 39/00
Applicant:
University of Zurich (Universität Zürich)
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16737975

MULTILAMELLAR LIPID VESICLE COMPOSITIONS INCLUDING A CONJUGATED ANAPLASTIC LYMPHOMA KINASE (ALK) VARIANT AND USES THEREOF

IPC classification:
A61K 9/127, A61K 39/395
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16703452

QUANTITATIVE ASSAY FOR HEAT SHOCK PROTEIN 70 (HSP70) PROTEIN IN BODY FLUIDS

IPC classification:
G01N 33/577, C07K 16/30, C07K 16/18, G01N 33/574
Applicant:
Klinikum rechts der Isar der Technischen Universität München
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16746000

MICROPROJECTION ARRAY APPLICATOR AND METHOD

IPC classification:
A61M 5/00, A61B 17/20, A61M 37/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16759492

COMPOSITIONS AND METHODS FOR TREATING OCULAR DISEASES

IPC classification:
A61K 47/48, A61K 31/74
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16759326

METHOD OF TREATING A LOCALIZED FIBROTIC DISORDER USING A TNF RECEPTOR 2 ANTAGONIST

IPC classification:
A61P 43/00, A61P 37/00, A61P 29/00, A61P 21/00, A61P 19/04, A61P 19/02, A61P 17/02, A61K 9/00, A61K 39/395, A61K 38/17, A61K 38/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16759325

METHOD OF TREATING A LOCALIZED FIBROTIC DISORDER USING AN IL-33 ANTAGONIST

IPC classification:
C07K 16/28
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17181249

NOVEL ANTI-FIBROBLAST ACTIVATION PROTEIN (FAP) BINDING AGENTS AND USES THEREOF

IPC classification:
C07K 16/30, C07K 14/725, A61K 39/00, C07K 16/40
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The application has been published
EP15886687

VASCULAR CASTED PROSTHESES AND METHODS OF FORMING SAME FOR TREATING BIOLOGICAL TISSUE

IPC classification:
A61L 27/36
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16719432

A NOVEL SKIN MEDICAL AND COSMETIC CARE PRODUCT

IPC classification:
A61K 38/39, A61Q 19/00, A61P 17/00, A61K 38/17
Applicant:
Universität Bremen
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16786968

WOUND PACKING MATERIAL COMPRISING CHEMOEFFECTOR

IPC classification:
A61M 1/00, A61F 13/36, A61F 13/02, A61L 15/22, A61L 15/16
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16812334

METHODS FOR THE TREATMENT OF LEPTOMENINGEAL CARCINOMATOSIS

IPC classification:
A61P 35/00, A61K 47/10, A61K 9/48, A61K 47/40
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16811672

PROTEIN EXPRESSION METHOD

IPC classification:
C12P 21/00, C07K 14/00, C07K 1/22, C12N 15/09
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16790192

PHARMACEUTICAL SUSPENSIONS CONTAINING DRUG PARTICLES, DEVICES FOR THEIR ADMINISTRATION, AND METHODS OF THEIR USE

IPC classification:
A61K 9/22, A61M 37/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP15902462

EXTRACELLULAR MATRIX PROSTHESES FOR TREATING DAMAGED BIOLOGICAL TISSUE

IPC classification:
A61L 27/36
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17211034

METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS

IPC classification:
C12Q 1/6886
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17206101

COATED MEDICAL ARTICLE FOR DRUG RELEASE

IPC classification:
A61P 31/04, A61L 31/10, A61L 29/16, A61L 29/08, A61L 15/44, A61L 15/22, A61L 31/16
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16853766

METHOD FOR PREPARING GENETICALLY-MODIFIED T CELLS WHICH EXPRESS CHIMERIC ANTIGEN RECEPTOR

IPC classification:
C12N 5/10, C07K 19/00, C07K 14/705, A61P 35/00, A61K 35/17, C12N 15/09
Applicant:
Shinshu University
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16858467

PROGNOSIS AND TREATMENT OF SQUAMOUS CELL CARCINOMAS

IPC classification:
G01N 33/574, C12Q 1/70, A61K 39/39, A61K 35/17
Applicant:
The Regents of the University of Colorado
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16861986

NOVEL GLUCOSE DEHYDROGENASE

IPC classification:
G01N 33/66, C12Q 1/54, C12N 15/09, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C12M 1/34, C12N 9/04
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17828179

PROSTHETIC TISSUE VALVES

IPC classification:
A61F 2/24
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17828180

PROSTHETIC TISSUE VALVES

IPC classification:
A61F 2/24
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP16881800

NOVEL BETA-GALACTOSIDASE

IPC classification:
C12P 19/00, C12N 9/38, C12N 5/10, C12N 1/21, C12N 1/19, C12N 1/15, C07H 3/06, C12N 15/09
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17741428

DIFFERENTIATION INDUCTION FROM HUMAN PLURIPOTENT STEM CELLS INTO HYPOTHALAMIC NEURONS

IPC classification:
C12N 5/0793, C12N 5/02, C12N 1/00, C12N 5/071
Applicant:
Nagoya University
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17757210

PEPTIDE-BASED METHODS FOR TREATING NEUROLOGICAL INJURY

IPC classification:
G01N 33/566, G01N 33/50, C12N 15/12
Applicant:
The Regents of the University of Colorado
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17760881

FEL D 1 KNOCKOUTS AND ASSOCIATED COMPOSITIONS AND METHODS BASED ON CRISPR-CAS9 GENOMIC EDITING

IPC classification:
C07K 14/435, C12N 9/12, C12N 15/90, C12N 15/87, C12N 9/22, A61K 38/46
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP18186664

ANCHORED CARDIOVASCULAR VALVE

IPC classification:
A61F 2/24
Applicant:
Cormatrix Cardiovascular Inc
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The application has been published
EP17763135

INDUCTION OF DIFFERENTIATION OF INDUCED PLURIPOTENT STEM CELLS INTO INTESTINAL EPITHELIAL CELLS

IPC classification:
G01N 33/50, G01N 33/15, C12Q 1/02, C12N 5/16, C12N 5/071, A61L 27/00, A61K 35/38, C12N 5/0735
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP18190279

PHARMACEUTICAL ANTI-TNF-ALPHA ANTIBODY FORMULATION

IPC classification:
A61K 39/00, A61K 47/00, A61K 47/18, A61K 47/10, A61K 39/395, C07K 16/24
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
The application has been published
EP17715858

METHODS OF TREATING AUTOIMMUNE DISEASE

IPC classification:
A61P 37/00, A61P 3/10, A61K 38/28, A61K 45/06, A61K 31/198
Applicant:
The Regents of the University of Colorado
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17779836

METHOD OF TREATING EARLY STAGE DUPUYTREN'S DISEASE

IPC classification:
A61K 49/16, A61K 39/44, A61K 39/395
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17792692

OPHTHALMIC DRUG SUSTAINED RELEASE DEVICE

IPC classification:
A61K 9/00, A61F 9/007
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17792653

PREDICTION OF HEPATOCELLULAR CARCINOMA ONSET AFTER CLEARANCE OF HEPATITIS C VIRUS

IPC classification:
G01N 33/68, G01N 33/53, G01N 33/50, C12Q 1/68, C12N 15/09
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17795686

COMBINATION PRIME: BOOST THERAPY

IPC classification:
A61P 37/04, A61P 35/00, A61K 39/00, C12N 7/01
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17798462

PSEUDOTYPED ONCOLYTIC RHABDOVIRUSES AND THEIR USE IN COMBINATION THERAPY

IPC classification:
C12N 15/86, C12N 15/47, C12N 15/40, C07K 14/145, A61P 35/00, A61K 45/06, A61K 39/00, A61K 35/766, C12N 7/01
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17807642

PREPARATION AND APPLICATIONS OF RGD CONJUGATED POLYSACCHARIDE BIOINKS WITH OR WITHOUT FIBRIN FOR 3D BIOPRINTING OF HUMAN SKIN WITH NOVEL PRINTING HEAD FOR USE AS MODEL FOR TESTING COSMETICS AND FOR TRANSPLANTATION

IPC classification:
G01N 33/50, C12Q 1/02, C12N 5/071, C12N 5/00, C12M 3/00, C12M 1/00, B29C 67/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17811137

PREPARATION OF MODIFIED CELLULOSE NANOFIBRILS WITH EXTRACELLULAR MATRIX COMPONENTS AS 3D BIOPRINTING BIOINKS

IPC classification:
A61L 27/26, A61L 29/16, A61L 27/58, A61L 27/54, A61L 27/56, C12N 5/074, C12N 5/02, A61K 31/717, C08B 15/02
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made
EP17814390

ADOPTIVE CELL TRANSFER AND ONCOLYTIC VIRUS COMBINATION THERAPY

IPC classification:
C12N 7/01, C12N 5/0783, C07K 16/28, A61P 37/02, A61P 35/04, A61P 35/00, A61K 35/768, A61K 35/66, A61K 39/00
Agent:
Peter Steinecke, Müller Fottner Steinecke Rechtsanwälte Patentanwälte PartGmbB
Status:
Request for examination was made

Please Sign in to use this feature